glp-1 news updates november 2025 Alarming rise in weight loss drug overdoses In U.S., GLP-1 Usage Reaches GLP-1-directed NMDA receptor antagonism for

Curcumin, as a CRM, has been found to have various biological activities such as antioxidant, anti-inflammatory, anti-rheumatic, anti-cancer, and anti-neurodegenerative activities, and can treat a variety of chronic diseases

For companies looking to develop ODT formulations, partnering with an experienced CDMO ensures optimized excipient selection, robust taste-masking strategies, and scalable manufacturing processes that meet regulatory requirements

Patients who failed to meet specific glycemic goals during the study were treated with glyburide (glibenclamide) rescue

Among those not taking the medications, 13% said they were likely to start in the future